Amended Safety Assessment of Methylisothiazolinone and Methylchloroisothiazolinone As Used in Cosmetics
Total Page:16
File Type:pdf, Size:1020Kb
Amended Safety Assessment of Methylisothiazolinone and Methylchloroisothiazolinone as Used in Cosmetics Status: Draft Report for Panel Review Release Date: May 10, 2019 Panel Meeting Date: June 6-7, 2019 The 2019 Cosmetic Ingredient Review Expert Panel members are: Chair, Wilma F. Bergfeld, M.D., F.A.C.P.; Donald V. Belsito, M.D.; Curtis D. Klaassen, Ph.D.; Daniel C. Liebler, Ph.D.; Ronald A. Hill, Ph.D. James G. Marks, Jr., M.D.; Ronald C. Shank, Ph.D.; Thomas J. Slaga, Ph.D.; and Paul W. Snyder, D.V.M., Ph.D. The CIR Executive Director is Bart Heldreth, Ph.D. This safety assessment was prepared by Christina L. Burnett, Senior Scientific Analyst/Writer. © Cosmetic Ingredient Review 1620 L St NW, Suite 1200 ◊ Washington, DC 20036-4702 ◊ ph 202.331.0651 ◊fax 202.331.0088 ◊ [email protected] Distributed for Comment Only -- Do Not Cite or Quote Commitment & Credibility since 1976 Memorandum To: CIR Expert Panel Members and Liaisons From: Christina L. Burnett, Senior Scientific Writer/Analyst Date: May 10, 2019 Subject: Draft Amended Report on the Safety Assessment on Methylisothiazolinone and Methylchloroisothiazolinone Enclosed is the draft amended report of the safety assessment of Methylisothiazolinone and Methylchloroisothiazolinone (MCI/MI) as used in cosmetics. (It is identified as mcimi062019rep in the pdf document.) This ingredient combination functions as a preservative in cosmetics. In 1992, the final report on MCI/MI was published with the conclusion that this mixture may be safely used in rinse-off products at a concentration not to exceed 15 ppm and in leave-on cosmetic products at a concentration not to exceed 7.5 ppm. (Minutes from the Panel discussions from 1987 to 1990 are identified as mcimi062019min_orig in the pdf document, while minutes from the more recent Panel discussions are identified as mcimi062019min.) At the April 2019 meeting, the Panel voted to re-open this safety assessment to reassess the conclusion based on the numerous sensitization studies and reports that have been published since 1992. The relevant data from these studies have been included in this draft report, along with summary information from the original report (indicated by italics). According to 2019 VCRP data, MCI and MI are reported separately and not as a mixture. The total number of uses reported for MCI are 5137; 480 of these are in leave-on products. MI has 6037 reported uses; 1042 of these are in leave-on products. The uses have increased significantly since the original report on MCI/MI was published; the 1986 total number of uses for the ingredient mixture was 381. Currently, the Council has reported the results of their survey that indicate MCI/MI (3:1) is used at up to 7.5 ppm in leave-on products and at up to 15 ppm in rinse-off products. In the original report, the ingredient combination was reported to be used at up to 1% in both leave-on and rinse-off products. Comments from the Council on the re-review document have been addressed and are included in this report package (mcimi062019pcpc). Data received since the April meeting include an open human repeated insult patch test of 12 ppm MCI/MI in a hand wash, updated concentration of use data, and the QRA2 risk assessment of MCI/MI performed by the CIR Science and Support Committee (mcimi062019data1 through mcimi062019data4). These data have been incorporated into the report and highlighted in yellow. If no further data are needed to reach a conclusion of safety, the Panel should formulate a Discussion and issue a Tentative Amended Report. However, if additional data are required, the Panel should be prepared to identify those needs and issue an Insufficient Data Announcement (IDA). __________________________________________________________________________________________ 1620 L St NW, Suite 1200, Washington, DC 20036 (Main) 202-331-0651 (Fax) 202-331-0088 (Email) [email protected] (Website) www.cir-safety.org Distributed for Comment Only -- Do Not Cite or Quote RE-REVIEW FLOW CHART INGREDIENT/FAMILY_____Methylisothiazolinone and Methylchlorothiazolinone ______ MEETING _______ June 2019___________________________________________________________ Public Comment CIR Expert Panel Re-Review Rpt Status New Data; or announce > 15 years OR request since last review JACT 11(1), 1992 Re-review to Panel PRIORITY LIST Apr 2019 Are new data cause to reopen? April 2019: Panel re- confirmed the decision to re-open this report YES NO DRAFT AMENDED REPORT DAR Are new ingredients June 2019 appropriate for inclusion/re-open? Table Table IDA TAR Yes No IDA Notice IDA RE-REVIEW Admin Book DRAFT TENTATIVE SUMMARY AMENDED REPORT Draft TAR Table Table Tentative Amended Report Issue TAR Draft FAR DRAFT FINAL 60 day Public comment period AMENDED REPORT Table Table Different Conclusion Final Amended Issue PUBLISH Report FAR Distributed for Comment Only -- Do Not Cite or Quote MCI/MI History 1992 – Safety Assessment of Methylisothiazolinone/Methylchloroisothiazolinone is published in the Journal of American College of Toxicology. April 2019 – Based on the multiple reported incidences of sensitization reported globally since the original report was published and the large number of uses being reported to the VCRP database, the Panel re-opened the safety assessment on MCI/MI to amend the current conclusion. Prior to determining the new conclusion, however, the Panel is awaiting the results of a second-generation quantitative risk assessment (QRA 2.0) calculation to be performed by industry stakeholders. Distributed for Comment Only -- Do Not Cite or Quote MCI/MI Data Profile* – June 2019 – Christina Burnett Repeated Dermal Dermal Ocular Clinical Toxicokinetics Acute Tox DART Genotox Carci Dose Tox Irritation Sensitization Irritation Studies ow Mfg ro /log K /log Vitro n Vit log P log Animal Retrospective/ Constituents/ Impurities Dermal Oral Inhalation Dermal Oral I In Vivo Dermal Oral In Vitro Animal Human In Vitro Animal Human Phototoxicity In Multicenter Case Reports Reported Use Method of Dermal Penetration ADME Dermal Oral Inhalation 1992 Report Data X X X X X X X X X X X X X X X X X X X X X 2019 Re-review X X X X X X X X * “X” indicates that data were available in a category for the ingredient 1 Distributed for Comment Only -- Do Not Cite or Quote MCI/MI – Christina Burnett Ingredient CAS # SciFin PubMed FDA EU ECHA SIDS ECETOC HPVIS NICNAS NTIS NTP WHO FAO NIOSH Web Methylchloroisot 26172-55-4 similar results Approve Annex Dossier hiazolinone/ and to below d for V only for Methylisothiazoli 2682-20-4 PubMed indirect MI none results food products MCI/MI – published in 1992 with the conclusion that this mixture may be safely used in rinse-off products at a concentration not to exceed 15 ppm and in leave-on cosmetic products at a concentration not to exceed 7.5 ppm. Search Strategy/PubMed – Search Performed in February 2019 Methylchloroisothiazolinoe OR Kathon – 541 hits 90 references ordered or downloaded. Search updated - April 24, 2019 Distributed for Comment Only -- Do Not Cite or Quote LINKS Search Engines . Pubmed (- http://www.ncbi.nlm.nih.gov/pubmed) . Scifinder (https://scifinder.cas.org/scifinder) appropriate qualifiers are used as necessary search results are reviewed to identify relevant documents Pertinent Websites . wINCI - http://webdictionary.personalcarecouncil.org . FDA databases http://www.ecfr.gov/cgi-bin/ECFR?page=browse . FDA search databases: http://www.fda.gov/ForIndustry/FDABasicsforIndustry/ucm234631.htm;, . EAFUS: http://www.accessdata.fda.gov/scripts/fcn/fcnnavigation.cfm?rpt=eafuslisting&displayall=true . GRAS listing: http://www.fda.gov/food/ingredientspackaginglabeling/gras/default.htm . SCOGS database: http://www.fda.gov/food/ingredientspackaginglabeling/gras/scogs/ucm2006852.htm . Indirect Food Additives: http://www.accessdata.fda.gov/scripts/fdcc/?set=IndirectAdditives . Drug Approvals and Database: http://www.fda.gov/Drugs/InformationOnDrugs/default.htm . http://www.fda.gov/downloads/AboutFDA/CentersOffices/CDER/UCM135688.pdf . FDA Orange Book: https://www.fda.gov/Drugs/InformationOnDrugs/ucm129662.htm . OTC ingredient list: https://www.fda.gov/downloads/aboutfda/centersoffices/officeofmedicalproductsandtobacco/cder/ucm135688.p df . (inactive ingredients approved for drugs: http://www.accessdata.fda.gov/scripts/cder/iig/ . HPVIS (EPA High-Production Volume Info Systems) - https://ofmext.epa.gov/hpvis/HPVISlogon . NIOSH (National Institute for Occupational Safety and Health) - http://www.cdc.gov/niosh/ . NTIS (National Technical Information Service) - http://www.ntis.gov/ . NTP (National Toxicology Program ) - http://ntp.niehs.nih.gov/ . Office of Dietary Supplements https://ods.od.nih.gov/ . FEMA (Flavor & Extract Manufacturers Association) - http://www.femaflavor.org/search/apachesolr_search/ . EU CosIng database: http://ec.europa.eu/growth/tools-databases/cosing/ . ECHA (European Chemicals Agency – REACH dossiers) – http://echa.europa.eu/information-on- chemicals;jsessionid=A978100B4E4CC39C78C93A851EB3E3C7.live1 . ECETOC (European Centre for Ecotoxicology and Toxicology of Chemicals) - http://www.ecetoc.org . European Medicines Agency (EMA) - http://www.ema.europa.eu/ema/ . IUCLID (International Uniform Chemical Information Database) - https://iuclid6.echa.europa.eu/search . OECD SIDS (Organisation for Economic Co-operation and Development Screening Info Data Sets)- http://webnet.oecd.org/hpv/ui/Search.aspx . SCCS (Scientific Committee for Consumer Safety) opinions: http://ec.europa.eu/health/scientific_committees/consumer_safety/opinions/index_en.htm